RETRACTED: Oxaliplatin activates P53/miR‐34a/survivin axis in inhibiting the progression of gastric cancer cells
Abstract Introduction The purpose of this research was to determine how the P53/microRNA‐34a (miR‐34a)/survivin pathway contributes to oxaliplatin‐induced (L‐OHP) cell inhibition in gastric cancer. Methods The BGC‐823 gastric cancer cells were selected, and we examined their viability following trea...
Saved in:
| Main Authors: | Qiang Guo, Xin‐Yuan Wang, Yan‐Chang Zhai, Yong‐Wei Dong, Qing‐Si He |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-09-01
|
| Series: | Immunity, Inflammation and Disease |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/iid3.70004 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibition of miR‐34a‐5p can rescue disruption of the p53‐DAPK axis to suppress progression of clear cell renal cell carcinoma
by: Zhi‐Fei Jing, et al.
Published: (2019-10-01) -
Baicalin-modified polyethylenimine for miR-34a efficient and safe delivery
by: Yingying Wang, et al.
Published: (2023-11-01) -
Correction: Baicalin-modifed polyethylenimine for miR-34a efficient and safe delivery
by: Yingying Wang, et al.
Published: (2025-07-01) -
The Effect of Ursodeoxycholic Acid (UDCA) on Serum Expression of miR-34a and miR-506 in Patients with Chronic Cholestatic Liver Diseases
by: Eliza Cielica, et al.
Published: (2025-07-01) -
Phytic acid potentiates oxaliplatin effects in colorectal cancer induced
by 1,2-DMH: the role of miR-224 and miR-200a
by: Tarek M. Okda, et al.
Published: (2021-05-01)